The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Coccidioidomycosis: A Descriptive Survey of a Reemerging Disease. Clinical Characteristics and Current Controversies
Abstract
Coccidioidomycosis is a fungal disease with protean manifestations endemic to the Lower Sonoran Life Zone, which includes the hot deserts of the southwestern United States and areas of Mexico. Two hundred and twenty-three patients were found to have coccidioidomycosis at our institution from 1994-2002, the largest reported cohort of coccidioidomycosis patients since the 1950s. Of these patients, 58% presented with isolated pulmonary disease, 14% had high (>1:16) complement fixation titers without clear evidence of dissemination, 22% had definite disseminated disease, and 5% had unclassified disease. Enzyme immunoassay was a reliable diagnostic tool in those with symptomatic disease, but had a low specificity in those who were asymptomatic. Complement fixation titers of > or =1:16 were associated with dissemination to bone or skin but were not helpful in evaluating central nervous system disease. Thirteen percent of patients with high complement fixation titers (>1:16) without clear evidence of dissemination on presentation and 7% of those with isolated pulmonary disease eventually progressed to disseminated disease; 30% of Filipino patients with pulmonary disease progressed to disseminated disease. Nonwhite race was a predictor for dissemination; African American patients more often developed disseminated bony disease while Filipinos were more likely to develop cutaneous or central nervous system disease. Relapse of disseminated coccidioidomycosis occurred in 24% of patients; the risk was highest (71%) among those with central nervous system disease. Azole therapy was generally inferior to amphotericin B in disseminated disease. Predictors of permanent disability included African American or Filipino race, central nervous system disease, and bony disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Coccidioidomycosis
Pappagianis, D. (1988) · Current Topics in Medical Mycology · doi:10.1007/978-1-4612-3730-3_6 · Cited by 322
Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases.
Smith, C. E., & Beard, R. R. (1946) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.36.12.1394 · Cited by 313
Galgiani, J. N., Catanzaro, A., Cloud, G. A., Johnson, R. H., Williams, P. L., Mirels, L. F., Nassar, F., Lutz, J. E., Stevens, D. A., Sharkey, P. K., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00009 · Cited by 294
Practice Guidelines for the Treatment of Coccidioidomycosis
Galgiani, J. N., Ampel, N. M., Catanzaro, A., Johnson, R. H., Stevens, D. A., & Williams, P. L. (2000) · Clinical Infectious Diseases · doi:10.1086/313747 · Cited by 275
Coccidioidomycosis: A Reemerging Infectious Disease
(1996) · Emerging Infectious Diseases · doi:10.3201/eid0203.960305 · Cited by 253
Rosenstein, N. E., Emery, K. W., Werner, S. B., Kao, A., Johnson, R., Rogers, D., Vugia, D., Reingold, A., Talbot, R., Plikaytis, B. D., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/319203 · Cited by 232
Chiller, T. M., Galgiani, J. N., & Stevens, D. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00040-5 · Cited by 218
Coccidioidomycosis in the Acquired Immunodeficiency Syndrome
BRONNIMANN, D. A., ADAM, R. D., GALGIANI, J. N., HABIB, M. P., PETERSEN, E. A., PORTER, B., & BLOOM, J. W. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-372 · Cited by 211
Is It Ever Safe To Stop Azole Therapy for Coccidioides immitis Meningitis?
Dewsnup, D. H., Galgiani, J. N., Graybill, J. R., Diaz, M., Rendon, A., Cloud, G. A., & Stevens, D. A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-3-199602010-00004 · Cited by 207
Fluconazole Therapy for Coccidioidal Meningitis
Galgiani, J. N., Catanzaro, A., Cloud, G. A., Higgs, J., Friedman, B. A., Larsen, R. A., Graybill, J. R., & and NIAID-Mycoses Study Group. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-1-199307010-00005 · Cited by 206
Cited by
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Galgiani, J. N., Ampel, N. M., Blair, J. E., Catanzaro, A., Geertsma, F., Hoover, S. E., Johnson, R. H., Kusne, S., Lisse, J., MacDonald, J. D., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw360 · Cited by 622
Epidemiology of endemic systemic fungal infections in Latin America
Colombo, A. L., Tobón, A., Restrepo, A., Queiroz-Telles, F., & Nucci, M. (2011) · Medical Mycology · doi:10.3109/13693786.2011.577821 · Cited by 400
Gadkowski, L. B., & Stout, J. E. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-07 · Cited by 388
Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007–2008
Tsang, C. A., Anderson, S. M., Imholte, S. B., Erhart, L. M., Chen, S., Park, B. J., Christ, C., Komatsu, K. K., Chiller, T., & Sunenshine, R. H. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1611.100475 · Cited by 140
Metadata
- Authors
- Crum, N. F., Lederman, E. R., Stafford, C. M., Parrish, J. S., & Wallace, M. R.
- Venue
- Medicine
- Published
- 2004-05
- Volume
- 83
- Issue
- 3
- Pages
- 149-175
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2013871628
- Cited by
- 265
- References
- 62
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coccidioidomycosis: A Descriptive Survey of a Reemerging Disease. Clinical Characteristics and Current Controversies. https://app.cochat.ai/papers/10.1097/01.md.0000126762.91040.fd
- The paper
- Crum, N. F., Lederman, E. R., Stafford, C. M., Parrish, J. S., & Wallace, M. R. (2004). Coccidioidomycosis: A Descriptive Survey of a Reemerging Disease. Clinical Characteristics and Current Controversies. Medicine. https://doi.org/10.1097/01.md.0000126762.91040.fd
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.